Clinical Nurse Specialists Lead with Evidence and Compassion in Addressing Fentanyl Exposure Concerns

“Evaluating the risks for nurses of fentanyl exposure and the harms of perpetuating exposure misinformation” (2025), nurses Corey Ranger, Patty Wilson, and Serena Eagland—leaders in harm reduction and outreach—emphasize the critical role of evidence-based practice in shaping policies that protect both healthcare workers and people who use drugs.

Despite public fear and political rhetoric, research continues to show that the risk of passive fentanyl exposure in clinical settings is extremely low. Yet, misinformation can lead to stigmatizing practices and create unnecessary fear among nurses—impacting patient care and staff well-being alike.

Clinical Nurse Specialists (CNSs) are uniquely positioned to analyze these risks, educate colleagues, and advocate for safe, inclusive, and dignified care environments. The authors—drawing on over 28 years of combined harm reduction experience—champion practical, compassionate solutions such as:

• Designated inhalation spaces to reduce staff exposure and keep patients safely on site.

• Access to a regulated safe supply to manage withdrawal and pain.

• Policy advocacy for harm reduction spaces within hospitals.

• Evidence-based communication that dispels myths and addresses staff concerns.

By confronting stigma with science and compassion, CNSs are leading systemic change that supports both nurse safety and equitable care. This is not a binary between nurse safety and patient rights—CNSs demonstrate that both are possible through leadership, collaboration, and courage.

Check out the webinar below: